| HCL | hairy-cell leukemia; human cultured lymphoblasts |
|---|---|
| HCl | hydrogen chloride |
| BN | Buprenorphine |
|---|---|
| BUP | Buprenorphine |
| Apo | Apomorphine HCl |
| HCL | Hairy Cell Leukaemia |
| DPPE | N,N-Diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine.HCl |
| buprenorphine | <chemical> 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol. A derivative of the opioid alkaloid thebaine that is a more potent and longer lasting analgesic than morphine. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. Pharmacological action: analgesics, opioid, narcotic antagonists, narcotics. Chemical name: 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- (12 Dec 1998) |
|---|---|
| buprenorphine hydrochloride | C29H41NO4-HCl;a semisynthetic opioid analgesic used for relief of moderate to severe pain. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
·¹³îÆÇÁÖ»ç - »õâ
|
ÇѸ²Á¦¾à |
G12700051 | Buprenorphine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
·¹³îÆÇÁÖ»ç0.2mg - »õâ
|
ÇѸ²Á¦¾à |
G12700061 | Buprenorphine HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¸í¹®¿°»êºÎÇÁ·¹³ë¸£ÇÉÁÖ»ç - »õâ
|
¸í¹®Á¦¾à |
G03700101 | Buprenorphine HCl | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|